SCM
NBP

Stonepine Capital Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Stonepine Capital Management’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-483,647
Closed -$398K – 71
2025
Q1 		$398K Buy
+483,647
New +$459K 0.39% 41

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Ariose Capital Management Central, Hong Kong, Hong Kong $234M AUM 640.82% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

Stonepine Capital Management's NBP Position: Q2 2025 in Review

Stonepine Capital Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2025, closing a stake of 483,647 shares — an estimated $398K sold.

Stonepine Capital Management first reported a position in NBP in Q1 2025 and held it in 1 quarter. The position peaked at $398K in Q1 2025. 32 funds tracked by Wall St. Rank hold NBP as of Q2 2025.

  • Stonepine Capital Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2025 after selling out during the quarter.
  • Stonepine Capital Management sold 483,647 NovaBridge Biosciences American Depositary Shares shares in Q2 2025, an estimated $398K.
  • Stonepine Capital Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2025 and held it in 1 quarter.
  • Stonepine Capital Management's NovaBridge Biosciences American Depositary Shares position peaked at $398K in Q1 2025.
  • 32 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2025.

Based on Stonepine Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.